Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
31 studies found for:    flumazenil
Show Display Options
Rank Status Study
1 Recruiting Treatment of Hepatic Encephalopathy With Flumazenil and Change in Cortical GABA Levels in MRS
Conditions: Hepatic Encephalopathy;   Liver Cirrhosis
Interventions: Drug: Flumazenil;   Drug: Placebo
2 Completed Safety and the Efficacy of a Sublingual Administration of Flumazenil to Reverse the Effect of Hypnotic Drugs in Healthy Adults
Condition: Healthy
Interventions: Drug: Flumazenil;   Drug: Placebo
3 Completed
Has Results
Flumazenil for the Treatment of Primary Hypersomnia
Conditions: Hypersomnia;   Primary Hypersomnia;   Idiopathic Hypersomnia;   Narcolepsy Without Cataplexy
Intervention: Drug: Flumazenil
4 Completed Electro-acupuncture and Flumazenil's Effect on Sedation
Conditions: Acupuncture;   General Anaesthesia;   Sedation
Interventions: Drug: Flumazenil;   Procedure: Acupuncture
5 Completed Effect of Flumazenil on Recovery From General Anesthesia With Isoflurane
Condition: Adverse Effect of Other General Anesthetics
Interventions: Drug: Flumazenil;   Drug: saline
6 Recruiting Flumazenil for Hypoactive Delirium Secondary to Benzodiazepine Toxicity
Condition: Delirium
Interventions: Drug: Flumazenil;   Drug: Placebo
7 Terminated Characterization of [11C]Flumazenil to Image GABA Transmission in Healthy Adult Subjects and Subjects With Alcohol Dependence
Condition: Alcoholism
Interventions: Radiation: [11C]flumazenil;   Drug: Tiagabine
8 Completed Flumazenil Reversal of Oral Triazolam
Condition: Dental Anxiety
Interventions: Drug: Flumazenil;   Drug: Placebo
9 Terminated A Randomized, Double-Blind, Placebo-Controlled Trial of Flumazenil for the Treatment of Obsessive Compulsive Disorder
Condition: Obsessive Compulsive Disorder
Intervention: Drug: Flumazenil
10 Completed Safety and Pharmacokinetic Study of Sublingual Flumazenil (CRLS035) in Healthy Adults
Condition: Insomnia
Intervention: Drug: Flumazenil
11 Completed Rapid Benzodiazepine Detoxification Using Flumazenil - 1
Condition: Substance-Related Disorders
Intervention: Drug: Flumazenil
12 Completed Positron Emission Tomography (PET) Study With (11C) Flumazenil to Determine Central GABAA Receptor Occupancy of AZD6280
Condition: Anxiety
Interventions: Drug: AZD6280;   Drug: (11C) flumazenil
13 Completed Positron Emission Tomography (PET) Study With (11C)Flumazenil to Determine Central GABAA Receptor Occupancy of AZD7325
Condition: Anxiety
Interventions: Drug: AZD7325;   Drug: Radioligand (11C) flumazenil
14 Completed
Has Results
Prometa Protocol for Alcohol Dependence
Condition: Alcohol Dependence
Interventions: Drug: Flumazenil and Gabapentin;   Drug: Placebo
15 Recruiting Prognosis Value of the Neuronal Damage in Early Multiple Sclerosis
Condition: Multiple Sclerosis
Intervention: Drug: PET with 11C-Flumazenil
16 Completed Effects of Flumazenil on Brain Excitability
Conditions: Stroke;   Healthy
17 Withdrawn Mild Traumatic Brain Injury and Post-Traumatic Stress Disorder
Conditions: Posttraumatic Stress Disorder;   Traumatic Brain Injury
18 Unknown  Neurocognitive Functioning Following The PROMETA® Treatment Protocol In Subjects With Alcohol Dependence
Condition: Alcohol Dependence
Intervention: Drug: Prometa Treatment Program
19 Terminated Effect of Repetitive Transcranial Magnetic Stimulation (rTMS) Over the Brain on the Neurotransmitter Binding
Conditions: Stroke;   Hemiplegia
Interventions: Device: Low frequency rTMS;   Device: High frequency rTMS;   Device: Sham rTMS
20 Recruiting A Study of IBRF Disorders of Consciousness Advanced Care/MultiModal Care Protocol in Severe Disorders of Consciousness
Condition: Brain Injury
Interventions: Drug: Polypharmacy using FDA-approved products;   Device: Median Nerve Stimulation (MNS);   Dietary Supplement: Nutraceutical Supplementation;   Other: Standard of Care

   Previous Page Studies Shown (1-20) Next Page (21-31) Show next page of results    Last Page
Indicates status has not been verified in more than two years